Updates matching "Cancer Research Funding"

American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Hawaii met with their legislators to urge them to fund a multiethnic cohort study by the University of Hawaii Cancer Center, the only National Cancer Institute-designated cancer center in the Hawaii Pacific region.

On behalf of cancer patients, survivors and their families, the American Cancer Society Cancer Action Network (ACS CAN) is pleased to see the president’s continued focus and dedication to achieving the goal of the Cancer Moonshot, to end cancer as we know it.

TRENTON, NJ – FEBRUARY 27, 2023 – Governor Murphy is expected to release his 2023-24 Executive Budget tomorrow, setting the legislative and fiscal agenda for the year. In anticipation, American Cancer Society Cancer Action Network (ACS CAN) New Jersey Government Relations Director Jade Bechelli, released the following statement: “In 2023,

Cancer patients, survivors, and caregivers from across the state traveled to the capitol in Austin to meet in person with their elected officials. They reminded legislators of their commitment to do all they could to prevent and treat cancer.

Indiana Must Do Better to Reduce the Burden of Cancer by Passing Fact-Based Legislation

The American Cancer Society Cancer Action Network (ACS CAN) applauds the president’s continued focus and dedication to achieving the goal of the Cancer Moonshot, to end cancer as we know it. President Biden outlined several strategies in the State of the Union to reduce the cancer burden nationwide.

Ahead of the President’s State of the Union Address, the American Cancer Society Cancer Action Network (ACS CAN) is calling on the President to emphasize the need for continued bipartisan support for increased federal investment in the fight against cancer.

American Cancer Society and ACS CAN statement on one-year anniversary of reignition of the Cancer Moonshot Initiative.

WASHINGTON, D.C.— Early this morning Congress released a proposed FY 2023 funding deal that includes an increase of $2.5 billion for biomedical research funding at the National Institutes of Health (NIH), $408 million more for cancer research at the National Cancer Institute (NCI) and provides a funding boost to cancer